AVP and Obesity: In summary, higher serum copeptin levels, a surrogate for AVP release, are associated not only with systolic and diastolic blood pressure but also with several components of metabolic syndrome including obesity, elevated concentration of triglycerides, albuminuria, and serum uric acid level.